Pharmaceutical Industry Trends & News - Pharmaceutical Technology

News

Novo Nordisk not currently in a position to pursue large-scale M&A, CEO says

Set against the backdrop of a mixed Q2, Novo is eyeing bolt-ons in favour of transformative acquisitions.

Robert Barrie

News

What is ‘Premium Content’ on Pharmaceutical Technology?

PremiumFeatures

Orexin receptor agonists set to propel narcolepsy treatment into a new era

Jam Bensilum

News

Mironid banks $46m in Series B to take rare kidney disease drug closer to clinic

News

AsymBio to secure $184m to support growth in biologics manufacturing

News

Phylo and Chugai collaborate to deploy AI platform in drug discovery

News

Pfizer repels Covid-19 sales tumble to raise 2026 guidance

News

Supernus and Indivior merge to create scaled, CNS-focused entity

Analysis

PremiumAnalyst Comment

What will health and social care look like under Andy Burnham?

GlobalData Healthcare

Features

Boosting CGT access: a global consideration with wide-spanning benefits

Annabel Kartal Allen

Analyst Comment

European drug manufacturers under threat from proposed US supply chain bill

GlobalData Healthcare

Analyst Comment

Cell and gene therapy manufacturers turn to specialist automation partners

GlobalData Healthcare

Themes

Partner Content

Industry partnership will determine the success of the transition to low-GWP pMDIs

With regulatory conditions tightening around climate impact and environmental persistence of medical propellants, HFA-152a is a practical route to maintain clinical performance, patient outcomes and supply continuity of inhalers. However,...

More themes

News

Bristol Myers, NVIDIA join forces to build life science’s ‘most powerful’ AI factory

Partner Content

Turning AI skeptics into AI advocates through high-integrity data

Partner Content

Keeping pace with generative AI in pharmaceutical and healthcare organisations

Analyst Comment

Pharma Meets AI Conference 2026: Key barriers to scaling AI in drug development

Data Insights

Cell & gene therapy: the leading companies in recombinant AAV gene therapy revealed

The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...

Data Insights

Leading clinical trials companies in the artificial intelligence theme

Data Insights

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

Data Insights

BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval

More Insights

Buyer's Guides

Buyer's Guides

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Buyer's Guides

Leading artificial intelligence (AI) companies in pharma

Buyer's Guides

Leading strategic intelligence solutions for the pharmaceutical industry

Buyer's Guides

Key lead generation providers and technology solutions for the pharmaceutical industry

GlobalData Reports

Q2 2026 CRO Activity and Intel Report

$1870.00

Pharma M&A Deals H1 2026 - Top Themes: Strategic Intelligence

$495.00

Diabetic Macular Edema in Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2035

$17995.00

Type 2 Diabetes (T2D): Epidemiology Forecast to 2035

$9995.00

Epilepsy (Adults) in Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2035

$17995.00

Digital Magazine

Latest Issue

Pharma Technology Focus

Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.

Sections

Sections

Sections

Sections

Sections

Sections

What is ‘Premium Content’ on Pharmaceutical Technology?

Orexin receptor agonists set to propel narcolepsy treatment into a new era

Mironid banks $46m in Series B to take rare kidney disease drug closer to clinic

AsymBio to secure $184m to support growth in biologics manufacturing

Phylo and Chugai collaborate to deploy AI platform in drug discovery

Pfizer repels Covid-19 sales tumble to raise 2026 guidance

Supernus and Indivior merge to create scaled, CNS-focused entity

What will health and social care look like under Andy Burnham?

Boosting CGT access: a global consideration with wide-spanning benefits

European drug manufacturers under threat from proposed US supply chain bill

Cell and gene therapy manufacturers turn to specialist automation partners

Industry partnership will determine the success of the transition to low-GWP pMDIs

Cell & gene therapy: the leading companies in recombinant AAV gene therapy revealed

Accelerate decision-making with data-led confidence

Leading clinical trials companies in the artificial intelligence theme

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Leading artificial intelligence (AI) companies in pharma

Leading strategic intelligence solutions for the pharmaceutical industry

Key lead generation providers and technology solutions for the pharmaceutical industry

Q2 2026 CRO Activity and Intel Report

Pharma M&A Deals H1 2026 - Top Themes: Strategic Intelligence

Diabetic Macular Edema in Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2035

Type 2 Diabetes (T2D): Epidemiology Forecast to 2035

Epilepsy (Adults) in Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2035

Pharma Technology Focus

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

Sign up for our daily news round-up!

Give your business an edge with our leading industry insights.

More themes

Accelerate decision-making with data-led confidence

More Insights

Q2 2026 CRO Activity and Intel Report

Pharma M&A Deals H1 2026 - Top Themes: Strategic Intelligence

Diabetic Macular Edema in Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2035

Type 2 Diabetes (T2D): Epidemiology Forecast to 2035

Epilepsy (Adults) in Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2035

Pharma Technology Focus

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

I would also like to subscribe to:

Thank you for subscribing